Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00101985 · ClinicalTrials.gov registry record · Phase 2
Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS)
A Phase 2 study of Irritable Colon, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 2
- Development phase
- 741
- Enrollment target
- 20
- Study locations
NCT00101985 is a Phase 2 study of Irritable Colon that has completed, run by GlaxoSmithKline. The registered enrollment target is 741 participants. The trial reports 20 study locations across 7 states.
The verdict
NCT00101985, a Phase 2 study of Irritable Colon, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 741 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study will evaluate the effectiveness and safety of the investigational drug talnetant in treating subjects with irritable bowel syndrome (IBS).
Conditions Studied
Interventions
- DRUG talnetant
Study Locations (20)
California
- GSK Investigational Site - Carmichael
- GSK Investigational Site - Concord
- GSK Investigational Site - Garden Grove
- GSK Investigational Site - Orange
- GSK Investigational Site - Roseville
- GSK Investigational Site - Spring Valley
- GSK Investigational Site - Torrance
Colorado
- GSK Investigational Site - Boulder
- GSK Investigational Site - Centennial
- GSK Investigational Site - Wheat Ridge
Connecticut
- GSK Investigational Site - Bristol
- GSK Investigational Site - Stamford
- GSK Investigational Site - Torrington
Florida
- GSK Investigational Site - DeLand
- GSK Investigational Site - Miami
- GSK Investigational Site - St. Petersburg
Arizona
- GSK Investigational Site - Chandler
- GSK Investigational Site - Phoenix
Arkansas
- GSK Investigational Site - North Little Rock
Delaware
- GSK Investigational Site - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 741 participants |
| Start Date | 2004-10 |
| Est. Completion | 2005-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00101985
The ClinicalTrials.gov registry entry for NCT00101985 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 741 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Irritable Colon appearing as the primary indexed condition, and to 1 intervention - of which talnetant is the first listed.
NCT00101985 reports 20 study locations spanning 7 distinct geographic areas - top geographies include California, Colorado, Connecticut.
Frequently Asked Questions
What is clinical trial NCT00101985 about?
NCT00101985 is a clinical study titled "Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS)". This study will evaluate the effectiveness and safety of the investigational drug talnetant in treating subjects with irritable bowel syndrome (IBS).
What is the current status of trial NCT00101985?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 741 participants. The study started on 2004-10. Estimated completion is 2005-07.
What conditions does trial NCT00101985 study?
This clinical trial studies the following conditions: Irritable Colon.
What interventions are being tested in trial NCT00101985?
The interventions under investigation include: talnetant (DRUG).
Who is sponsoring clinical trial NCT00101985?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00101985 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Irritable Colon
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.